Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
leuprolide (lupron) (1 trial)
Hodgkin Disease (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Multiple Myeloma (Phase 2)
Trials (1 total)
Trial APIs (1 total)